CSF3 and breast carcinoma: However, all of these promoting effects could be attenuated or abolished by treatments with the G-CSF-neutralizing antibody (Figure 4) or a Stat3-targeting small-molecule inhibitor (Figure 5), demonstrating that G-CSF is a crucial and functional mediator in the adipocyte/CAA–breast cancer crosstalk.